We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 03 JULY 2012
PMPRB Reconsiders And Issues New Decision On Quadracel® And Pentacel®

Gowling WLG
Contributor

Gowling WLG
The firm The firm’s lawyers speak English, French, Russian and Ukrainian. The firm’s client base...
View firm profileThe PMPRB released its June 14, 2012 decision relating to Sanofi Pasteur’s vaccines QUADRACEL and PENTACEL.
CanadaIntellectual Property




